Insider plans sale of 2,293 Eton (NASDAQ: ETON) shares under Rule 144

Rhea-AI Filing Summary

Eton Pharmaceuticals insider plans a modest stock sale under Rule 144. A notice was filed to sell 2,293 shares of common stock through Raymond James & Associates, with an aggregate market value of $35,483.96, on or about 01/14/2026 on the NASDAQ. The filing notes that 26,820,000 shares of the issuer’s common stock were outstanding.

The securities to be sold are part of 6,469 common shares acquired on 01/13/2026 via a grant from the issuer, with cash noted as the form of payment dated 01/14/2026. Over the prior three months, James R. Gruber sold 4,524 common shares on 12/12/2025 for gross proceeds of $76,883.00. The signer represents that they are not aware of any undisclosed material adverse information about the issuer.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates 880 Carillon Parkway St. Petersburg FL 33716	2293	35483.96	26820000	01/14/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/13/2026	Grant	Issuer			6469	01/14/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
James R. Gruber 618 Ames St Libertyville IL 60048	Common	12/12/2025	4524	76883.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filing for ETON disclose?

The Form 144 notice discloses an insider’s intent to sell 2,293 shares of Eton Pharmaceuticals common stock, with an aggregate market value of $35,483.96, on or about 01/14/2026 via NASDAQ.

Who is selling ETON shares and how many have they sold recently?

The filing lists James R. Gruber as a seller. In the past three months he sold 4,524 common shares on 12/12/2025 for gross proceeds of $76,883.00, and now gives notice to sell an additional 2,293 shares.

How were the ETON shares to be sold under Form 144 acquired?

The shares were part of 6,469 common shares acquired on 01/13/2026 by grant from the issuer, with cash indicated as the nature of payment dated 01/14/2026.

Which broker will handle the planned ETON share sale?

The planned sale of 2,293 Eton common shares is to be handled by Raymond James & Associates, located at 880 Carillon Parkway, St. Petersburg, FL 33716.

How many ETON shares are outstanding according to this notice?

The notice states that there are 26,820,000 shares of Eton Pharmaceuticals common stock outstanding.

What assurance does the seller provide about ETON’s information?

By signing, the person for whose account the securities are to be sold represents that they do not know of any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.